Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Naomi Lynn Gerber, MD

LICENSE # 0101239685
 
Issue Date: 3/31/2006
Expiration Date: 2/28/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 2/2/2024
Georgetown University School Of Medicine - Washington DC
Rank: no longer active appointment
Years:

Academic Appointments - Non-US
Last Updated 2/2/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 2/2/2024
Relationships among neurotransmitters, cytokines, cognitive performance for individuals with hepatitis C achieving sustained viral response: A pilot study
j Neuroimmun
Volume: 15
Date: 10 2019
doi: 10.1016/j.jneuroim.2019.577022.

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
J Hep
Date: 08 2020
doi: 10.1016/j.jhepr.2020.100171

Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease.
J Clin Hypertens
Date: 09 2020
doi: 10.1111/jch.13938. Epub ahead of print.

Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease.
Life
Volume: 11
Date: 02 2021
doi: 10.3390/life11080799.

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.
Clin Ifec Dis
Date: 06 2021
doi: 10.1093/cid/ciab579.

Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19Infection.
Hepatolo Communications
Date: 08 2021
DOI 10.1002/hep4.1802.